ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,998 | -74.2% | 15,162 | 0.0% | 0.00% | – |
| Q2 2023 | $7,733 | -19.0% | 15,162 | 0.0% | 0.00% | – |
| Q1 2023 | $9,552 | -41.5% | 15,162 | -39.7% | 0.00% | – |
| Q4 2022 | $16,333 | -62.0% | 25,162 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $43,000 | +38.7% | 25,162 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $31,000 | +93.8% | 25,162 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | -40.7% | 25,162 | 0.0% | 0.00% | – |
| Q4 2021 | $27,000 | -41.3% | 25,162 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $46,000 | -13.2% | 25,162 | +24.8% | 0.00% | 0.0% |
| Q2 2021 | $53,000 | -27.4% | 20,162 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $73,000 | -73.4% | 20,162 | -81.4% | 0.00% | -80.0% |
| Q3 2020 | $274,000 | +80.3% | 108,681 | +134.3% | 0.01% | +66.7% |
| Q2 2020 | $152,000 | +33.3% | 46,378 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $114,000 | -42.4% | 46,378 | +10.8% | 0.00% | -25.0% |
| Q4 2019 | $198,000 | +44.5% | 41,866 | +30.7% | 0.00% | +33.3% |
| Q3 2019 | $137,000 | -29.7% | 32,028 | -4.0% | 0.00% | -25.0% |
| Q2 2019 | $195,000 | +51.2% | 33,378 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $129,000 | +118.6% | 33,378 | +6.4% | 0.00% | +50.0% |
| Q4 2018 | $59,000 | -41.0% | 31,378 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $100,000 | -58.8% | 31,378 | -19.8% | 0.00% | -75.0% |
| Q2 2017 | $243,000 | -2.0% | 39,108 | 0.0% | 0.01% | -11.1% |
| Q1 2017 | $248,000 | +18.7% | 39,108 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $209,000 | -5.0% | 39,108 | 0.0% | 0.01% | -10.0% |
| Q3 2016 | $220,000 | +2.3% | 39,108 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $215,000 | -33.6% | 39,108 | -10.3% | 0.01% | -37.5% |
| Q1 2016 | $324,000 | -2.7% | 43,608 | +8.7% | 0.02% | -5.9% |
| Q4 2015 | $333,000 | -5.4% | 40,108 | +2.6% | 0.02% | -5.6% |
| Q3 2015 | $352,000 | -42.0% | 39,108 | -22.7% | 0.02% | -35.7% |
| Q2 2015 | $607,000 | +61.0% | 50,616 | +44.6% | 0.03% | +64.7% |
| Q1 2015 | $377,000 | -32.4% | 35,000 | -68.2% | 0.02% | -34.6% |
| Q4 2014 | $558,000 | +606.3% | 110,000 | +266.7% | 0.03% | +550.0% |
| Q3 2014 | $79,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |